JPH08507303A - 非競合的nmda受容体アンタゴニストとしての2h−1,2,4−ベンゾチアジアジン3(4h)−オン1,1ジオキシド誘導体の使用 - Google Patents
非競合的nmda受容体アンタゴニストとしての2h−1,2,4−ベンゾチアジアジン3(4h)−オン1,1ジオキシド誘導体の使用Info
- Publication number
- JPH08507303A JPH08507303A JP6519646A JP51964694A JPH08507303A JP H08507303 A JPH08507303 A JP H08507303A JP 6519646 A JP6519646 A JP 6519646A JP 51964694 A JP51964694 A JP 51964694A JP H08507303 A JPH08507303 A JP H08507303A
- Authority
- JP
- Japan
- Prior art keywords
- dioxide
- formula
- nmda receptor
- benzothiadiazin
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR93/02439 | 1993-03-03 | ||
FR9302439A FR2702150B1 (fr) | 1993-03-03 | 1993-03-03 | Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA. |
PCT/FR1994/000207 WO1994020109A1 (fr) | 1993-03-03 | 1994-02-25 | Application de derives de 2h-1,2,4-benzothiadiazine-3(4h)-one-1,1-dioxyde comme antagonistes non competitifs du recepteur nmda |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08507303A true JPH08507303A (ja) | 1996-08-06 |
Family
ID=9444603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6519646A Pending JPH08507303A (ja) | 1993-03-03 | 1994-02-25 | 非競合的nmda受容体アンタゴニストとしての2h−1,2,4−ベンゾチアジアジン3(4h)−オン1,1ジオキシド誘導体の使用 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0687178A1 (no) |
JP (1) | JPH08507303A (no) |
AU (1) | AU6143694A (no) |
CA (1) | CA2153951A1 (no) |
FR (1) | FR2702150B1 (no) |
HU (1) | HU9502572D0 (no) |
IL (1) | IL108784A0 (no) |
NO (1) | NO953387D0 (no) |
PL (1) | PL310439A1 (no) |
WO (1) | WO1994020109A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CN101668525A (zh) | 2007-03-01 | 2010-03-10 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶抑制剂的新用途 |
EP2142514B1 (en) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB975925A (en) * | 1961-02-21 | 1964-11-25 | Scherico Ltd | 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides |
US4716161A (en) * | 1984-04-17 | 1987-12-29 | Mitsubishi Chemical Industries Limited | Phenylpiperazine derivatives and their acid addition salts |
FR2675801A1 (fr) * | 1991-04-24 | 1992-10-30 | Rhone Poulenc Rorer Sa | Piperidines, leur preparation et les medicaments les contenant. |
AU3957093A (en) * | 1992-04-15 | 1993-11-18 | Rhone-Poulenc Rorer S.A. | 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same |
FR2690160A1 (fr) * | 1992-04-15 | 1993-10-22 | Rhone Poulenc Rorer Sa | Application de dérivés d'acide 2H-1,2,4-benzothiadiazine-1,1-dioxyde-3-carboxylique à la préparation de médicaments, les produits nouveaux, leur préparation et les médicaments les contenant. |
-
1993
- 1993-03-03 FR FR9302439A patent/FR2702150B1/fr not_active Expired - Fee Related
-
1994
- 1994-02-25 CA CA002153951A patent/CA2153951A1/fr not_active Abandoned
- 1994-02-25 AU AU61436/94A patent/AU6143694A/en not_active Abandoned
- 1994-02-25 JP JP6519646A patent/JPH08507303A/ja active Pending
- 1994-02-25 EP EP94908373A patent/EP0687178A1/fr not_active Withdrawn
- 1994-02-25 HU HU9502572A patent/HU9502572D0/hu unknown
- 1994-02-25 WO PCT/FR1994/000207 patent/WO1994020109A1/fr not_active Application Discontinuation
- 1994-02-25 PL PL94310439A patent/PL310439A1/xx unknown
- 1994-02-28 IL IL10878494A patent/IL108784A0/xx unknown
-
1995
- 1995-08-29 NO NO953387A patent/NO953387D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
PL310439A1 (en) | 1995-12-11 |
WO1994020109A1 (fr) | 1994-09-15 |
CA2153951A1 (fr) | 1994-09-15 |
NO953387L (no) | 1995-08-29 |
NO953387D0 (no) | 1995-08-29 |
AU6143694A (en) | 1994-09-26 |
FR2702150B1 (fr) | 1995-04-07 |
EP0687178A1 (fr) | 1995-12-20 |
HU9502572D0 (en) | 1995-11-28 |
IL108784A0 (en) | 1994-06-24 |
FR2702150A1 (fr) | 1994-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4316794B2 (ja) | イソキノリン誘導体及び医薬 | |
EP0858996B1 (en) | Nerve cell protective agents | |
AU2014204831C1 (en) | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | |
PT1133474E (pt) | Derivados da 4-arilquinolin-2-ona substituidos em 3 posições utilizados como moduladores do canal de potássio. | |
FR2477542A1 (fr) | Derives de carbostyrile, leurs procedes de preparation et leur application en therapeutique | |
JPH06501004A (ja) | αアドレナリン作働剤としての6−または7−(2−イミノ−2−イミダゾリジン)−1,4−ベンゾオキサジン | |
HUT75307A (en) | 5h-indeno[1,2-b]pyrazine-2,3-dione derivaties, preparation thereof and drugs containing same | |
JPH04230681A (ja) | 1,4‐ベンゾチアゼピン誘導体 | |
JPH02290841A (ja) | 新規化合物、その製法及びそれを含む医薬組成物 | |
JPH08507303A (ja) | 非競合的nmda受容体アンタゴニストとしての2h−1,2,4−ベンゾチアジアジン3(4h)−オン1,1ジオキシド誘導体の使用 | |
EP1148881A1 (fr) | UTILISATION DE DERIVES DE PYRIDAZINO [4,5-(b)]-INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES | |
JP2010024243A (ja) | 緑内障および近視を処置するためのベンゾ[g]キノリン誘導体 | |
JPH11508280A (ja) | 三環式アミノアルキルカルボキサミド;新規なドーパミンd▲下3▼受容体サブタイプに特異的なリガンド | |
HU190648B (en) | Process for preparing n-substituted 2,3,4,5-tetra-hydro-1h-3-benzazepine derivatives | |
RU2685501C1 (ru) | Амидсодержащие производные 2-оксиндола, способ их получения и применения | |
US6602865B1 (en) | Pyridazino(4,5-b)(1,5)oxazepinone, -thiazepinone and -diazepinone compounds | |
JP2023503091A (ja) | Trpv4受容体リガンド | |
JP4216337B2 (ja) | ベンゾ[g]キノリン誘導体 | |
DE69107874T2 (de) | Imidazolderivate und diese Imidazolderivate als Wirkstoffe enthaltende Antiepileptika. | |
CZ321095A3 (en) | Heterocyclic compounds | |
JP2005519117A (ja) | キノリン誘導体 | |
WO2006088080A1 (ja) | シクロヘプタ[b]ピリジン-3-カルボニルグアニジン誘導体およびそれを含有する医薬品 | |
EP3375784A1 (en) | Aza-dihydro-acridone derivatives | |
RU2352563C2 (ru) | Атропоизомеры производных 3-замещенного-4-арилхинолин-2-она | |
JPH0776573A (ja) | ヘテロ環化合物、その製造法および剤 |